Clinical trial

Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients…

NCT00002702 · European Institute of Oncology, Other · Unknown status

Key facts

NCT number NCT00002702
Title Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx
Official title Multicentre Randomised Trial of Inductive and Adjuvant Perilymphatically Injected Proleukin (rlL-2) in The Treatment of Operable Primary Squamous Cell Carcinoma of The Oral Cavity and Oropharynx
Lead sponsor European Institute of Oncology, Other
Status Unknown status
Phase Phase 3
Study type Interventional
Conditions Head and Neck Cancer
Intervention type Biological, Procedure, Radiation
Interventions aldesleukin, adjuvant therapy, conventional surgery, neoadjuvant therapy, radiation therapy
Enrollment 260
Start date Sep 1, 1992
First posted Jan 27, 2003
Last update posted Aug 26, 2013
Countries Italy

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies